|
|
|
|
|
|
|
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
|
| |
|
June 13, 2017 |
|
|
|
|
|
|
|
|
Netzealous LLC DBA - Compliance4All, Online
2017-08-10
Overview: The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.
Why should you Attend: FDA expects that as part of a product development program risk management will be conducted. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard. Hazard Analysis is the most powerful of the risk management tools described in ISO 14971 but it is very confusing. Many new concepts are introduced.
Areas Covered in the Session: Explanation of Hazard Analysis terms Hazard analysis Process explanation using a template Examples of terms will be given Hazard analysis examples will be covered step by step
Who Will Benefit: Engineer Engineering Manager Regulatory Personnel QA
Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com
|
|
|
|
|
|
Organized by:
|
|
Netzealous LLC DBA - Compliance4All |
|
Invited Speakers:
|
|
Speaker Profile: Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2017-08-16
|
|
|
|
|
|
Registration:
|
|
Full Details & Registration Link: http://www.compliance4all.com/control/w_product/~product_id=501363LIVE?channel=bio-mirror_Aug_2017_SEO
|
|
E-mail:
|
|
support@compliance4All.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|